diagnosis of primary infertility for 15 years. Due to anovulation and asthenozoospermia (motility 27.8%) and consideration of
mg/day ϫ 10 days in the mid-luteal phase). Two oocytes A 36 year-old infertile female developed a stage IV (FIGO)
were retrieved from the left ovary and inseminated in vitro. ovarian carcinoma consisting of a poorly differentiated Unfortunately, the oocytes did not show two pronuclei 24 h Sertoli-Leydig cell tumour after receiving one course of after insemination. Intracytoplasmic sperm injection (ISCI) was ovulation induction with follicle stimulating hormone performed to re-inseminate the unfertilized oocytes, but in vain.
(FSH), human menopausal gonadotrophin (HMG) and
During the course of stimulated ovulation, an ovarian cyst, human chorionic gonadotrophin (HCG) followed by gon-3.2ϫ2.5 cm, was observed in the right ovary. During oocyte adotrophin-releasing hormone analogue (GnRHa). The retrieval, a chocolate-like fluid was drained from the right patient died of liver metastasis and hepatic failure 4 1 2 ovarian cyst, which confirmed the diagnosis of endometrioma. months after first diagnosis, despite aggressive treatment Danazol 800 mg was administered daily to treat the endomeconsisting of debulking surgery and aggressive adjuvant triosis for 1 month. The regimen was changed to leuplin depot chemotherapy.
3.75 mg s.c. injection once a month in the following 2 months. Key words: ART/infertility/Sertoli-Leydig cell tumour/stimuTen days after the second dose of leuplin depot, she was admitted lated ovulation and operated for a right adnexal solid tumour and massive ascites, associated with multiple liver nodules and pleural effusion. During the laparotomy, we found massive ascites and a right side solid ovarian tumour entrapping the sigmoid colon, posterior Introduction aspect of uterus and left side ovary presenting as a frozen pelvis. The size of the right ovarian tumour was 15 cm in diameter. Ovarian stimulation is the preliminary procedure of all assisted Diffuse multiple metastatic nodules were seen in the liver. A reproductive techniques (ART) in infertility treatment. Several solitary tumour of irregular surface was also found in the area articles have reported the presence of ovarian cancers in infertile of the junction of the caecum and appendix. Optimal debulking females receiving clomiphene citrate and gonadotrophin. There surgery (residual tumour Ͻ1 cm) was performed. Pathological has been much debate on the 'incessant-ovulation and ovarian examination showed the tumour to be mainly composed of cancer of epithelial origin' hypothesis. Nevertheless, the relaSertoli tubules which had arisen from the gonadal stromal cells tionship between ovarian cancer and stimulated ovulation still with rare Leydig cell clusters ( Figure 1 ). The Sertoli cells focally remains uncertain. In literature reports concerning association had pleomorphic and anaplastic nuclei. Immunochemical study between ovarian carcinomas and stimulated ovulation, serous showed that the Sertoli tubular cells were positive for α-adenocarcinoma has been the second most common histological fetoprotein and focally for carcinoembryonic antigen (CEA), type (Atlas et al., 1982; Carter et al., 1987; Kulkami et al., 1989;  rarely for vimentin and negative for epithelial membrane antigen Dietl, 1991; Goldberg et al., 1992; Lopes et al., 1992; Balasch (EMA et al., 1995) and endometroid ovarian carcinoma (Bamford mg/m 2 ), etoposide (100 mg/m 2 , D2,3,4) and bleomycin (25 et al., 1982) . To our knowledge, this is the first report of a Sertoli-Leydig cell tumour in an infertile female receiving ART. mg/m 2 , D2,3,4), the patient died of hepatic failure. 
Discussion
Leuplin depot is a type of GnRHa which reduces the release of luteinizing hormone (LH) and FSH by down- Fathalla (1967) and Stevenson (1970) first reported that patients regulation. Immediately after administration of GnRHa, a with endometriosis had a higher incidence of ovarian cancer.
period of up-regulation occurs which usually lasts 4-6 days. Despite extensive study of ovarian cancers, no definite aetiology Feldberg et al. (1989) reported ovarian cyst formation in has been established. However, several risk factors and profive of the 22 patients in the period of up-regulation after tecting factors for ovarian cancer have been found in previous buserelin (900 mg, days 1-3; Superfact, Hoechst A.G., research. Patients with infertility have a higher incidence of Frankfurt, Germany) administration. Whether or not the epithelial ovarian cancer (Lingeman, 1983; Negri et al., 1991) .
repeated up-regulation of GnRHa is one of the factors In contrast, pregnancy and the use of oral contraceptives are inducing the malignant transformation of a silent tumour thought to have protective roles (Heintz et al., 1985; Wu et al., remains uncertain. 1988) . Fathalla (1971) proposed the hypothesis that ovarian Reviewing the case reports, ovarian cancers associated cancer was related to incessant ovulation. Zajicek (1977) also with infertility were predominantly serous adenocarcinoma observed the association between ovarian cystomas and ovulaor granulosa cell carcinoma. To our knowledge, no case of tion. This supported the possibility of the malignant transformaSertoli-Leydig cell tumour has been reported similar to the tion of ovarian surface epithelium and follicle lining epithelium current one. Sertoli-Leydig cell tumours are usually divided during repeated trauma and repairing. Meanwhile, oral contrainto three groups based on the differentiation: good, ceptive pills and pregnancy can protect the ovary by suppression intermediate and poor. The survival rate is significantly of ovulation (Scott, 1984) .
higher in patients in the good differentiation category, as Whittemore et al. (1992) reported that infertile females using compared to patients in the moderate and poor differentiation fertility drugs were 27 times more likely to develop ovarian categories (Scully, 1979; Roth et al., 1981; Zaloudek et al. , cancer than a fertile female. These results were reappraised by 1984; Young et al., 1985) . The current case was a poorly Balasch et al. (1993) , who disputed the relationship between differentiated stage IV disease. The interval between diagnosis ovarian cancer and fertility treatment. The cause of increased to mortality was 4 1 2 months despite aggressive adjuvant risk of ovarian cancer in infertile patients may be the underlying chemotherapy following debulking surgery. disorder, rather than the use of fertility drugs. In the current case, Although no direct connection can be found between the long protocol of GnRHa plus FSH (metrodin, 150 IUϫ8 fertility drugs and ovarian cancer, a tumour of rapid growth days), HMG (Pergonal, two ampoulesϫ9 days) followed by is noteworthy. It should be kept in mind that ascites occurring HCG (10 000 IU) was used for one cycle. Before initiating in patients receiving ovulation induction may indicate a ovulation induction, a small cyst diagnosed as endometrioma diagnosis of ovarian cancer other than ovarian hyperstimulawas noted and persisted through stimulated ovulation to oocyte tion syndrome. Patients with endometrioma should be closely retrieval. During oocyte retrieval, transvaginal sonographic followed up with CA-125 measurement and sonography examination demonstrated an endometrioma in the right ovary, performed through the course of ovulation induction and the diagnosis being proved by the chocolate-like content. No even after oocyte retrieval. Moreover, cells retrieved during abnormal mass implying ovarian tumour or Sertoli-Leydig cell oocyte retrieval should be subjected to cytological examinatumour was found in the same scan. The relationship between fertility drugs and Sertoli-Leydig cell tumour was not definite.
tion to rule out the possibility of malignant change.
